509 related articles for article (PubMed ID: 16449996)
1. Promoter methylation of P16, RARbeta, E-cadherin, cyclin A1 and cytoglobin in oral cancer: quantitative evaluation using pyrosequencing.
Shaw RJ; Liloglou T; Rogers SN; Brown JS; Vaughan ED; Lowe D; Field JK; Risk JM
Br J Cancer; 2006 Feb; 94(4):561-8. PubMed ID: 16449996
[TBL] [Abstract][Full Text] [Related]
2. Promoter hypermethylation profile of ovarian epithelial neoplasms.
Makarla PB; Saboorian MH; Ashfaq R; Toyooka KO; Toyooka S; Minna JD; Gazdar AF; Schorge JO
Clin Cancer Res; 2005 Aug; 11(15):5365-9. PubMed ID: 16061849
[TBL] [Abstract][Full Text] [Related]
3. Methylation enrichment pyrosequencing: combining the specificity of MSP with validation by pyrosequencing.
Shaw RJ; Akufo-Tetteh EK; Risk JM; Field JK; Liloglou T
Nucleic Acids Res; 2006 Jun; 34(11):e78. PubMed ID: 16807314
[TBL] [Abstract][Full Text] [Related]
4. p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner.
Su PF; Huang WL; Wu HT; Wu CH; Liu TY; Kao SY
Oral Oncol; 2010 Oct; 46(10):734-9. PubMed ID: 20729138
[TBL] [Abstract][Full Text] [Related]
5. Molecular staging of surgical margins in oral squamous cell carcinoma using promoter methylation of p16(INK4A), cytoglobin, E-cadherin, and TMEFF2.
Shaw RJ; Hobkirk AJ; Nikolaidis G; Woolgar JA; Triantafyllou A; Brown JS; Liloglou T; Risk JM
Ann Surg Oncol; 2013 Aug; 20(8):2796-802. PubMed ID: 23111707
[TBL] [Abstract][Full Text] [Related]
6. Hypermethylation of multiple genes in tumor tissues and voided urine in urinary bladder cancer patients.
Chan MW; Chan LW; Tang NL; Tong JH; Lo KW; Lee TL; Cheung HY; Wong WS; Chan PS; Lai FM; To KF
Clin Cancer Res; 2002 Feb; 8(2):464-70. PubMed ID: 11839665
[TBL] [Abstract][Full Text] [Related]
7. Aberrant promoter methylation of multiple genes in non-small cell lung cancers.
Zöchbauer-Müller S; Fong KM; Virmani AK; Geradts J; Gazdar AF; Minna JD
Cancer Res; 2001 Jan; 61(1):249-55. PubMed ID: 11196170
[TBL] [Abstract][Full Text] [Related]
8. Patterns of gene promoter methylation in squamous cell cancer of the head and neck.
Hasegawa M; Nelson HH; Peters E; Ringstrom E; Posner M; Kelsey KT
Oncogene; 2002 Jun; 21(27):4231-6. PubMed ID: 12082610
[TBL] [Abstract][Full Text] [Related]
9. Aberrant promoter methylation in Chinese patients with non-small cell lung cancer: patterns in primary tumors and potential diagnostic application in bronchoalevolar lavage.
Chan EC; Lam SY; Tsang KW; Lam B; Ho JC; Fu KH; Lam WK; Kwong YL
Clin Cancer Res; 2002 Dec; 8(12):3741-6. PubMed ID: 12473584
[TBL] [Abstract][Full Text] [Related]
10. Aberrant gene promoter methylation of E-cadherin, p16
Burassakarn A; Pientong C; Sunthamala N; Chuerduangphui J; Vatanasapt P; Patarapadungkit N; Kongyingyoes B; Ekalaksananan T
Med Oncol; 2017 Jul; 34(7):128. PubMed ID: 28573642
[TBL] [Abstract][Full Text] [Related]
11. Hypermethylation-associated inactivation of retinoic acid receptor beta in human esophageal squamous cell carcinoma.
Wang Y; Fang MZ; Liao J; Yang GY; Nie Y; Song Y; So C; Xu X; Wang LD; Yang CS
Clin Cancer Res; 2003 Nov; 9(14):5257-63. PubMed ID: 14614007
[TBL] [Abstract][Full Text] [Related]
12. The correlation between CpG methylation and protein expression of P16 in oral squamous cell carcinomas.
Huang MJ; Yeh KT; Shih HC; Wang YF; Lin TH; Chang JY; Shih MC; Chang JG
Int J Mol Med; 2002 Nov; 10(5):551-4. PubMed ID: 12373290
[TBL] [Abstract][Full Text] [Related]
13. Mapping the methylation pattern by bisulfite genomic sequencing of the E-cadherin promoter CpG island in nasopharyngeal carcinoma.
Kao RH; Huang LC; Hsu YH
Anticancer Res; 2002; 22(6C):4109-13. PubMed ID: 12553040
[TBL] [Abstract][Full Text] [Related]
14. The correlation between CpG methylation on promoter and protein expression of E-cadherin in oral squamous cell carcinoma.
Yeh KT; Shih MC; Lin TH; Chen JC; Chang JY; Kao CF; Lin KL; Chang JG
Anticancer Res; 2002; 22(6C):3971-5. PubMed ID: 12553020
[TBL] [Abstract][Full Text] [Related]
15. Epigenetic abnormalities in cutaneous squamous cell carcinomas: frequent inactivation of the RB1/p16 and p53 pathways.
Murao K; Kubo Y; Ohtani N; Hara E; Arase S
Br J Dermatol; 2006 Nov; 155(5):999-1005. PubMed ID: 17034532
[TBL] [Abstract][Full Text] [Related]
16. Status of p16(INK4a) and E-cadherin gene promoter methylation in Moroccan patients with cervical carcinoma.
Attaleb M; El hamadani W; Khyatti M; Benbacer L; Benchekroun N; Benider A; Amrani M; El Mzibri M
Oncol Res; 2009; 18(4):185-92. PubMed ID: 20112504
[TBL] [Abstract][Full Text] [Related]
17. Comprehensive epigenetic analysis using oral rinse samples: a pilot study.
Kusumoto T; Hamada T; Yamada N; Nagata S; Kanmura Y; Houjou I; Kamikawa Y; Yonezawa S; Sugihara K
J Oral Maxillofac Surg; 2012 Jun; 70(6):1486-94. PubMed ID: 21821326
[TBL] [Abstract][Full Text] [Related]
18. [The p16 methylation in oral leukoplakia and oral squamous cell carcinoma].
Liu HW; Hu BQ; Cao CF
Zhonghua Kou Qiang Yi Xue Za Zhi; 2005 Mar; 40(2):94-7. PubMed ID: 15842853
[TBL] [Abstract][Full Text] [Related]
19. CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
Ribeiro-Filho LA; Franks J; Sasaki M; Shiina H; Li LC; Nojima D; Arap S; Carroll P; Enokida H; Nakagawa M; Yonezawa S; Dahiya R
Mol Carcinog; 2002 Aug; 34(4):187-98. PubMed ID: 12203370
[TBL] [Abstract][Full Text] [Related]
20. Characterization of a multiple epigenetic marker panel for lung cancer detection and risk assessment in plasma.
Hsu HS; Chen TP; Hung CH; Wen CK; Lin RK; Lee HC; Wang YC
Cancer; 2007 Nov; 110(9):2019-26. PubMed ID: 17876837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
